JOHNSON & JOHNSON - 10%+ Owner at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
CTNM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by JOHNSON & JOHNSON since 08 Jan 2025

Holdings reported by JOHNSON & JOHNSON for Contineum Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 1,979,173 $33,744,900 $17.05 09 Apr 2024 Indirect

There are no transactions reported by JOHNSON & JOHNSON for Contineum Therapeutics, Inc.